Phase 2 Trial of Tremelimumab in Patients With Metastatic Urothelial Cancer Previously Treated With PD-1/PD-L1 Blockade

Learn more:

• https://clinicaltrials.gov/study/NCT03557918

Manuscripts/Articles:

• E Miller, T Rose, B Maughan, M Milowsky, M Bilen, B Carthon, X Gao, S Rapisuwon, Q Zhao, M Yu, N Agarwal, M Galsky. Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade HCRN-GU17-294. DOI: 10.1002/cncr.35179 Cancer. 2024 January 5. See Abstract.